Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth Prostate Cancer Diagnostic Included in NCCN Early Detection Guidelines

NEW YORK (GenomeWeb) – MDxHealth announced today that its ConfirmMDx for Prostate Cancer screening test has been included in the US 2016 National Comprehensive Cancer Network (NCCN) Guidelines for prostate cancer screening.

"Tests that improve specificity in the post-biopsy state — including 4Kscore, PHI, percent free PSA, PCA3, and ConfirmMDx — should be considered in patients thought to be higher risk despite a negative prostate biopsy," the NCCN guidelines now say.

ConfirmMDx is an epigenetic tissue-based test, and provides a negative predictive value of 90 percent for all prostate cancers, and 96 percent for clinically significant prostate cancers, the company said. The test results can also help guide repeat prostate biopsies.

In 2013, the NCCN also included MDxHealth's PredictMDx for Glioblastoma test in its guidelines for gauging MGMT methylation status in central nervous system cancers.

"Inclusion in the guidelines establishes ConfirmMDx as a 'standard of care' for the management of men at risk for undetected prostate cancer," said CEO Jan Groen in a statement. "This is the second MDxHealth test to be included in the NCCN guidelines, with PredictMDx for Glioblastoma added in 2013, and illustrates our commitment to delivering clinically valuable solutions to improve patient outcomes."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.